{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T20:04:31Z","timestamp":1794859471323,"version":"4.9.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:00:00Z","timestamp":1768608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr Metab (Lond)"],"DOI":"10.1186\/s12986-026-01084-6","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T10:25:24Z","timestamp":1768645524000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mendelian randomization identifies causal effects of phospholipids on portal vein thrombosis risk: FADS1\/2-mediated pathways and their potential as diagnostic biomarkers"],"prefix":"10.1186","volume":"23","author":[{"given":"Yuwei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,17]]},"reference":[{"key":"1084_CR1","doi-asserted-by":"publisher","DOI":"10.1160\/TH16-10-0781","author":"W Ageno","year":"2017","unstructured":"Ageno W, Dentali F, Pomero F, et al. Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari syndrome. Thromb Haemost. 2017. https:\/\/doi.org\/10.1160\/TH16-10-0781.","journal-title":"Thromb Haemost"},{"key":"1084_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ejim.2022.05.032","volume":"104","author":"J Pan","year":"2022","unstructured":"Pan J, Wang L, Gao F, et al. Epidemiology of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis. Eur J Intern Med. 2022;104:21\u201332. https:\/\/doi.org\/10.1016\/j.ejim.2022.05.032.","journal-title":"Eur J Intern Med"},{"issue":"01","key":"1084_CR3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1160\/TH16-06-0450","volume":"26","author":"P Ambrosino","year":"2017","unstructured":"Ambrosino P, Tarantino L, Minno GD, et al. The risk of venous thromboembolism in patients with cirrhosis. Thromb Haemost. 2017;26(01):139\u201348. https:\/\/doi.org\/10.1160\/TH16-06-0450.","journal-title":"Thromb Haemost"},{"issue":"5","key":"1084_CR4","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/S1499-3872(13)60081-8","volume":"12","author":"MX Li","year":"2013","unstructured":"Li MX, Zhang XF, Liu ZW, Lv Y. Risk factors and clinical characteristics of portal vein thrombosis after splenectomy in patients with liver cirrhosis. Hepatobiliary Pancreat Dis Int. 2013;12(5):512\u20139. https:\/\/doi.org\/10.1016\/S1499-3872(13)60081-8.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"1084_CR5","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.12659\/MSM.898866","volume":"22","author":"X Qi","year":"2016","unstructured":"Qi X, Han G, Ye C, et al. Splenectomy causes 10-fold increased risk of portal venous system thrombosis in liver cirrhosis patients. Med Sci Monit. 2016;22:2528\u201350. https:\/\/doi.org\/10.12659\/MSM.898866.","journal-title":"Med Sci Monit"},{"issue":"2","key":"1084_CR6","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.jhep.2021.04.029","volume":"75","author":"M Senzolo","year":"2021","unstructured":"Senzolo M, Garcia-Tsao G, Garc\u00eda-Pag\u00e1n JC. Current knowledge and management of portal vein thrombosis in cirrhosis. J Hepatol. 2021;75(2):442\u201353. https:\/\/doi.org\/10.1016\/j.jhep.2021.04.029.","journal-title":"J Hepatol"},{"issue":"2","key":"1084_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.dld.2016.11.013","volume":"49","author":"C Margini","year":"2017","unstructured":"Margini C, Berzigotti A. Portal vein thrombosis: the role of imaging in the clinical setting. Dig Liver Dis. 2017;49(2):113\u201320. https:\/\/doi.org\/10.1016\/j.dld.2016.11.013.","journal-title":"Dig Liver Dis"},{"issue":"8","key":"1084_CR8","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s10654-017-0251-1","volume":"32","author":"VM Morelli","year":"2017","unstructured":"Morelli VM, Lijfering WM, Bos MHA, Rosendaal FR, Cannegieter SC. Lipid levels and risk of venous thrombosis: results from the MEGA-study. Eur J Epidemiol. 2017;32(8):669\u201381. https:\/\/doi.org\/10.1007\/s10654-017-0251-1.","journal-title":"Eur J Epidemiol"},{"issue":"3","key":"1084_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.5937\/jomb0-27106","volume":"40","author":"I Spasi\u0107","year":"2021","unstructured":"Spasi\u0107 I, Ubavi\u0107 M, \u0160umarac Z, Todorovi\u0107 M, Vu\u010dkovi\u0107 B. Influence of lipid metabolism disorders on venous thrombosis risk. J Med Biochem. 2021;40(3):245\u201351. https:\/\/doi.org\/10.5937\/jomb0-27106.","journal-title":"J Med Biochem"},{"issue":"1","key":"1084_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/rth2.12017","volume":"1","author":"H Deguchi","year":"2017","unstructured":"Deguchi H, Elias DJ, Griffin JH. Minor plasma lipids modulate clotting factor activities and may affect thrombosis risk. Res Pract Thromb Haemost. 2017;1(1):93\u2013102. https:\/\/doi.org\/10.1002\/rth2.12017.","journal-title":"Res Pract Thromb Haemost"},{"key":"1084_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02204","volume":"10","author":"L Guo","year":"2019","unstructured":"Guo L, Rondina MT. The era of thromboinflammation: platelets are dynamic sensors and effector cells during infectious diseases. Front Immunol. 2019;10:2204. https:\/\/doi.org\/10.3389\/fimmu.2019.02204.","journal-title":"Front Immunol"},{"issue":"1","key":"1084_CR12","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1080\/07853890.2022.2028893","volume":"54","author":"Y Xing","year":"2022","unstructured":"Xing Y, Tian Z, Jiang Y, et al. A practical nomogram based on systemic inflammatory markers for predicting portal vein thrombosis in patients with liver cirrhosis. Ann Med. 2022;54(1):302\u20139. https:\/\/doi.org\/10.1080\/07853890.2022.2028893.","journal-title":"Ann Med"},{"issue":"16","key":"1084_CR13","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, Richmond RC, Woolf BAR, et al. Strengthening the reporting of observational studies in epidemiology using Mendelian Randomization: the STROBE-MR statement. JAMA. 2021;326(16):1614\u201321. https:\/\/doi.org\/10.1001\/jama.2021.18236.","journal-title":"JAMA"},{"issue":"10","key":"1084_CR14","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1681\/ASN.2020121760","volume":"32","author":"A Tin","year":"2021","unstructured":"Tin A, K\u00f6ttgen A. Mendelian randomization analysis as a tool to gain insights into causes of diseases: a primer. J Am Soc Nephrol. 2021;32(10):2400\u20137. https:\/\/doi.org\/10.1681\/ASN.2020121760.","journal-title":"J Am Soc Nephrol"},{"issue":"16","key":"1084_CR15","doi-asserted-by":"publisher","first-page":"7395","DOI":"10.1073\/pnas.0912019107","volume":"107","author":"BM Neale","year":"2010","unstructured":"Neale BM, Fagerness J, Reynolds R, et al. Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci U S A. 2010;107(16):7395\u2013400. https:\/\/doi.org\/10.1073\/pnas.0912019107.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1084_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/liv.15466","volume":"43","author":"J Ma","year":"2023","unstructured":"Ma J, Li J, Jin C, et al. Association of gut microbiome and primary liver cancer: a two-sample Mendelian randomization and case\u2013control study. Liver Int. 2023;43(1):221\u201333. https:\/\/doi.org\/10.1111\/liv.15466.","journal-title":"Liver Int"},{"key":"1084_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03691-2","volume":"20","author":"G Xiao","year":"2022","unstructured":"Xiao G, He Q, Liu L, et al. Causality of genetically determined metabolites on anxiety disorders: a two-sample Mendelian randomization study. J Transl Med. 2022;20:475. https:\/\/doi.org\/10.1186\/s12967-022-03691-2.","journal-title":"J Transl Med"},{"key":"1084_CR18","doi-asserted-by":"publisher","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.3","volume":"4","author":"S Burgess","year":"2019","unstructured":"Burgess S, Davey Smith G, Davies NM, et al. Guidelines for performing Mendelian randomization investigations: update for summer 2023. Wellcome Open Res. 2019;4:186. https:\/\/doi.org\/10.12688\/wellcomeopenres.15555.3.","journal-title":"Wellcome Open Res"},{"issue":"3","key":"1084_CR19","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ije\/dyr036","volume":"40","author":"S Burgess","year":"2011","unstructured":"Burgess S, Thompson SG. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011;40(3):755\u201364. https:\/\/doi.org\/10.1093\/ije\/dyr036.","journal-title":"Int J Epidemiol"},{"key":"1084_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03648-5","volume":"20","author":"J Cai","year":"2022","unstructured":"Cai J, Li X, Wu S, et al. Assessing the causal association between human blood metabolites and the risk of epilepsy. J Transl Med. 2022;20:437. https:\/\/doi.org\/10.1186\/s12967-022-03648-5.","journal-title":"J Transl Med"},{"issue":"6","key":"1084_CR21","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1093\/ije\/dyw220","volume":"45","author":"J Bowden","year":"2016","unstructured":"Bowden J, Del Greco MF, Minelli C, Davey Smith G, Sheehan NA, Thompson JR. Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic. Int J Epidemiol. 2016;45(6):1961\u201374. https:\/\/doi.org\/10.1093\/ije\/dyw220.","journal-title":"Int J Epidemiol"},{"issue":"4","key":"1084_CR22","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304\u201314. https:\/\/doi.org\/10.1002\/gepi.21965.","journal-title":"Genet Epidemiol"},{"issue":"11","key":"1084_CR23","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1681\/ASN.2016010098","volume":"27","author":"P Sekula","year":"2016","unstructured":"Sekula P, Del Greco MF, Pattaro C, K\u00f6ttgen A. Mendelian randomization as an approach to assess causality using observational data. J Am Soc Nephrol. 2016;27(11):3253\u201365. https:\/\/doi.org\/10.1681\/ASN.2016010098.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"1084_CR24","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693\u20138. https:\/\/doi.org\/10.1038\/s41588-018-0099-7.","journal-title":"Nat Genet"},{"issue":"7","key":"1084_CR25","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/aje\/kwt084","volume":"178","author":"BL Pierce","year":"2013","unstructured":"Pierce BL, Burgess S. Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators. Am J Epidemiol. 2013;178(7):1177\u201384. https:\/\/doi.org\/10.1093\/aje\/kwt084.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"1084_CR26","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","volume":"32","author":"S Burgess","year":"2017","unstructured":"Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017;32(5):377\u201389. https:\/\/doi.org\/10.1007\/s10654-017-0255-x.","journal-title":"Eur J Epidemiol"},{"issue":"11","key":"1084_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007081","volume":"13","author":"G Hemani","year":"2017","unstructured":"Hemani G, Tilling K, Davey Smith G. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet. 2017;13(11):e1007081. https:\/\/doi.org\/10.1371\/journal.pgen.1007081.","journal-title":"PLoS Genet"},{"issue":"5","key":"1084_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004383","volume":"10","author":"C Giambartolomei","year":"2014","unstructured":"Giambartolomei C, Vukcevic D, Schadt EE, et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 2014;10(5):e1004383. https:\/\/doi.org\/10.1371\/journal.pgen.1004383.","journal-title":"PLoS Genet"},{"issue":"5","key":"1084_CR29","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.ejvs.2018.01.027","volume":"55","author":"Y Sung","year":"2018","unstructured":"Sung Y, Spagou K, Kafeza M, et al. Deep vein thrombosis exhibits characteristic serum and vein wall metabolic phenotypes in the inferior vena cava ligation mouse model. Eur J Vasc Endovasc Surg. 2018;55(5):703\u201313. https:\/\/doi.org\/10.1016\/j.ejvs.2018.01.027.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"9","key":"1084_CR30","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.3324\/haematol.2023.284566","volume":"109","author":"W Huang","year":"2024","unstructured":"Huang W, Zou Y, Zhang K, et al. Two-sample Mendelian randomization analysis reveals causal relationships between blood lipids and venous thromboembolism. Haematologica. 2024;109(9):2978\u201387. https:\/\/doi.org\/10.3324\/haematol.2023.284566.","journal-title":"Haematologica"},{"issue":"6","key":"1084_CR31","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.jhep.2011.03.017","volume":"55","author":"G Li","year":"2011","unstructured":"Li G, Chen W, Han C, Wu T. Cytosolic Phospholipase A2\u03b1 Protects Against Fas-But Not Lps-Induced Liver Injury. J Hepatol. 2011;55(6):1281\u201390. https:\/\/doi.org\/10.1016\/j.jhep.2011.03.017.","journal-title":"J Hepatol"},{"issue":"8","key":"1084_CR32","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1111\/bph.14196","volume":"176","author":"M Crescente","year":"2019","unstructured":"Crescente M, Menke L, Chan MV, Armstrong PC, Warner TD. Eicosanoids in platelets and the effect of their modulation by aspirin in the cardiovascular system (and beyond). Br J Pharmacol. 2019;176(8):988\u201399. https:\/\/doi.org\/10.1111\/bph.14196.","journal-title":"Br J Pharmacol"},{"issue":"6","key":"1084_CR33","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1161\/01.ATV.0000222960.43792.ff","volume":"26","author":"CD Funk","year":"2006","unstructured":"Funk CD. Lipoxygenase pathways as mediators of early inflammatory events in atherosclerosis. Arterioscler Thromb Vasc Biol. 2006;26(6):1204\u20136. https:\/\/doi.org\/10.1161\/01.ATV.0000222960.43792.ff.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"1084_CR34","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1161\/01.RES.78.5.780","volume":"78","author":"T Murohara","year":"1996","unstructured":"Murohara T, Scalia R, Lefer AM. Lysophosphatidylcholine promotes P-selectin expression in platelets and endothelial cells. Circ Res. 1996;78(5):780\u20139. https:\/\/doi.org\/10.1161\/01.RES.78.5.780.","journal-title":"Circ Res"},{"issue":"5","key":"1084_CR35","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/09537109876564","volume":"9","author":"Jacek Watala","year":"1998","unstructured":"Watala Jacek, Golanski Magdalena A., Boncler Tadeusz, Pietrucha Krzysztof, Gwozdzinski C. Membrane lipid fluidity of blood platelets: a common denominator that underlies the opposing actions of various agents that affect platelet activation in whole blood. Platelets. 1998;9(5):315\u201327. https:\/\/doi.org\/10.1080\/09537109876564.","journal-title":"Platelets"},{"issue":"22","key":"1084_CR36","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.010317","volume":"7","author":"X Jiang","year":"2018","unstructured":"Jiang X, Zeleznik OA, Lindstr\u00f6m S, et al. Metabolites associated with the risk of incident venous thromboembolism: a metabolomic analysis. J Am Heart Assoc. 2018;7(22):e010317. https:\/\/doi.org\/10.1161\/JAHA.118.010317.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"1084_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/0033-0620(87)90011-9","volume":"30","author":"M Aviram","year":"1987","unstructured":"Aviram M, Gerald Brook J. Platelet activation by plasma lipoproteins. Prog Cardiovasc Dis. 1987;30(1):61\u201372. https:\/\/doi.org\/10.1016\/0033-0620(87)90011-9.","journal-title":"Prog Cardiovasc Dis"},{"key":"1084_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.925923","volume":"9","author":"H Jiang","year":"2022","unstructured":"Jiang H, Zhou Y, Nabavi SM, et al. Mechanisms of oxidized LDL-mediated endothelial dysfunction and its consequences for the development of atherosclerosis. Front Cardiovasc Med. 2022;9:925923. https:\/\/doi.org\/10.3389\/fcvm.2022.925923.","journal-title":"Front Cardiovasc Med"},{"issue":"17","key":"1084_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176150","volume":"21","author":"K Hally","year":"2020","unstructured":"Hally K, Fauteux-Daniel S, Hamzeh-Cognasse H, Larsen P, Cognasse F. Revisiting platelets and toll-like receptors (TLRs): at the interface of vascular immunity and thrombosis. Int J Mol Sci. 2020;21(17):6150. https:\/\/doi.org\/10.3390\/ijms21176150.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"1084_CR40","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1194\/jlr.D029546","volume":"53","author":"S Huang","year":"2012","unstructured":"Huang S, Rutkowsky JM, Snodgrass RG, et al. Saturated fatty acids activate TLR-mediated proinflammatory signaling pathways. J Lipid Res. 2012;53(9):2002\u201313. https:\/\/doi.org\/10.1194\/jlr.D029546.","journal-title":"J Lipid Res"},{"issue":"7","key":"1084_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20071641","volume":"20","author":"K Hsia","year":"2019","unstructured":"Hsia K, Lin CH, Lee HY, et al. Sphingosine-1-phosphate in endothelial cell recellularization improves patency and endothelialization of decellularized vascular grafts in vivo. Int J Mol Sci. 2019;20(7):1641. https:\/\/doi.org\/10.3390\/ijms20071641.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1084_CR42","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1080\/09537100050057675","volume":"11","author":"DN Xu","year":"2000","unstructured":"Xu DN, Yan. Sphingosine-1-phosphate: characterization of its Inhibition of platelet aggregation. Platelets. 2000;11(4):226\u201332. https:\/\/doi.org\/10.1080\/09537100050057675.","journal-title":"Platelets"},{"issue":"5","key":"1084_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/nu8050247","volume":"8","author":"CL Lyons","year":"2016","unstructured":"Lyons CL, Kennedy EB, Roche HM. Metabolic inflammation-differential modulation by dietary constituents. Nutrients. 2016;8(5):247. https:\/\/doi.org\/10.3390\/nu8050247.","journal-title":"Nutrients"},{"issue":"5","key":"1084_CR44","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1161\/ATVBAHA.111.242388","volume":"32","author":"YS Bynagari-Settipalli","year":"2012","unstructured":"Bynagari-Settipalli YS, Lakhani P, Jin J, et al. Protein kinase C isoform epsilon (\u03b5) negatively regulates ADP-induced calcium mobilization and thromboxane generation in platelets. Arterioscler Thromb Vasc Biol. 2012;32(5):1211\u20139. https:\/\/doi.org\/10.1161\/ATVBAHA.111.242388.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"1084_CR45","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/s0003-4975(10)61557-3","volume":"35","author":"R Zajtchuk","year":"1983","unstructured":"Zajtchuk R, Zajtchuk J. Relationship of triglyceride levels to thrombosis in patients with coronary artery disease. Ann Thorac Surg. 1983;35(3):274\u20136. https:\/\/doi.org\/10.1016\/s0003-4975(10)61557-3.","journal-title":"Ann Thorac Surg"},{"issue":"10","key":"1084_CR46","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1161\/01.ATV.0000143134.87051.46","volume":"24","author":"CJM Doggen","year":"2004","unstructured":"Doggen CJM, Smith NL, Lemaitre RN, Heckbert SR, Rosendaal FR, Psaty BM. Serum lipid levels and the risk of venous thrombosis. Arterioscler Thromb Vasc Biol. 2004;24(10):1970\u20135. https:\/\/doi.org\/10.1161\/01.ATV.0000143134.87051.46.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"1084_CR47","doi-asserted-by":"publisher","first-page":"C659","DOI":"10.1152\/ajpcell.1994.267.3.C659","volume":"267","author":"MW Lee","year":"1994","unstructured":"Lee MW, Severson DL. Signal transduction in vascular smooth muscle: diacylglycerol second messengers and PKC action. Am J Physiol-Cell Physiol. 1994;267(3):C659-78. https:\/\/doi.org\/10.1152\/ajpcell.1994.267.3.C659.","journal-title":"Am J Physiol-Cell Physiol"},{"issue":"4","key":"1084_CR48","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.thromres.2005.04.001","volume":"117","author":"Y Ijiri","year":"2006","unstructured":"Ijiri Y, Naemura A, Yamashita T, et al. Dietary diacylglycerol extenuates arterial thrombosis in apoE and LDLR deficient mice. Thromb Res. 2006;117(4):411\u20137. https:\/\/doi.org\/10.1016\/j.thromres.2005.04.001.","journal-title":"Thromb Res"},{"issue":"9","key":"1084_CR49","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1161\/ATVBAHA.118.311410","volume":"38","author":"PA Laurent","year":"2018","unstructured":"Laurent PA, Hechler B, Solinhac R, et al. Impact of PI3K\u03b1 (Phosphoinositide 3-kinase alpha) inhibition on hemostasis and thrombosis. Arterioscler Thromb Vasc Biol. 2018;38(9):2041\u201353. https:\/\/doi.org\/10.1161\/ATVBAHA.118.311410.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"1084_CR50","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1093\/eurheartj\/eht496","volume":"35","author":"EW Holy","year":"2014","unstructured":"Holy EW, Jakob P, Eickner T, et al. PI3K\/p110\u03b1 Inhibition selectively interferes with arterial thrombosis and Neointima formation, but not re-endothelialization: potential implications for drug-eluting stent design. Eur Heart J. 2014;35(12):808\u201320. https:\/\/doi.org\/10.1093\/eurheartj\/eht496.","journal-title":"Eur Heart J"},{"issue":"5","key":"1084_CR51","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1182\/blood-2014-07-588335","volume":"125","author":"PA Laurent","year":"2015","unstructured":"Laurent PA, S\u00e9verin S, Hechler B, Vanhaesebroeck B, Payrastre B, Gratacap MP. Platelet PI3K\u03b2 and GSK3 regulate thrombus stability at a high shear rate. Blood. 2015;125(5):881\u20138. https:\/\/doi.org\/10.1182\/blood-2014-07-588335.","journal-title":"Blood"},{"issue":"11","key":"1084_CR52","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/s42255-019-0132-x","volume":"1","author":"M Seldin","year":"2019","unstructured":"Seldin M, Yang X, Lusis AJ. Systems genetics applications in metabolism research. Nat Metab. 2019;1(11):1038\u201350. https:\/\/doi.org\/10.1038\/s42255-019-0132-x.","journal-title":"Nat Metab"},{"issue":"3","key":"1084_CR53","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/hep4.1629","volume":"5","author":"S Athinarayanan","year":"2021","unstructured":"Athinarayanan S, Fan YY, Wang X, et al. Fatty acid desaturase 1 influences hepatic lipid homeostasis by modulating the PPAR\u03b1-FGF21 axis. Hepatol Commun. 2021;5(3):461\u201377. https:\/\/doi.org\/10.1002\/hep4.1629.","journal-title":"Hepatol Commun"},{"issue":"4","key":"1084_CR54","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2904131","volume":"29","author":"Q Liu","year":"2024","unstructured":"Liu Q, Wang P, Yang Z, Dai Y, Wang S. Targeted knockdown of hepatic \u0394-5 fatty acid desaturase FADS1 aggravates atherosclerosis in ApoE-\/- mice. Front Biosci (Landmark Ed). 2024;29(4):131. https:\/\/doi.org\/10.31083\/j.fbl2904131.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"6","key":"1084_CR55","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3760\/cma.j.cn501113-20240229-00100","volume":"32","author":"YW Wang","year":"2024","unstructured":"Wang YW, Ding HG. [New targets for the prevention and treatment of cirrhotic portal vein thrombosis]. Zhonghua Gan Zang Bing Za Zhi. 2024;32(6):484\u20138. https:\/\/doi.org\/10.3760\/cma.j.cn501113-20240229-00100.","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"10","key":"1084_CR56","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1016\/j.bbadis.2019.06.016","volume":"1865","author":"Y Chen","year":"2019","unstructured":"Chen Y, Weng Z, Liu Q, et al. FMO3 and its metabolite TMAO contribute to the formation of gallstones. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2019;1865(10):2576\u201385. https:\/\/doi.org\/10.1016\/j.bbadis.2019.06.016.","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"issue":"1","key":"1084_CR57","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cell.2016.02.011","volume":"165","author":"W Zhu","year":"2016","unstructured":"Zhu W, Gregory JC, Org E, et al. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell. 2016;165(1):111\u201324. https:\/\/doi.org\/10.1016\/j.cell.2016.02.011.","journal-title":"Cell"},{"issue":"6","key":"1084_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065806","volume":"24","author":"G Querio","year":"2023","unstructured":"Querio G, Antoniotti S, Geddo F, Levi R, Gallo MP. Modulation of endothelial function by TMAO, a gut microbiota-derived metabolite. Int J Mol Sci. 2023;24(6):5806. https:\/\/doi.org\/10.3390\/ijms24065806.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1084_CR59","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s11739-020-02470-5","volume":"16","author":"L Guasti","year":"2021","unstructured":"Guasti L, Galliazzo S, Molaro M, et al. TMAO as a biomarker of cardiovascular events: a systematic review and meta-analysis. Intern Emerg Med. 2021;16(1):201\u20137. https:\/\/doi.org\/10.1007\/s11739-020-02470-5.","journal-title":"Intern Emerg Med"},{"key":"1084_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1217338","volume":"14","author":"XY Huang","year":"2023","unstructured":"Huang XY, Zhang YH, Yi SY, et al. Potential contribution of the gut microbiota to the development of portal vein thrombosis in liver cirrhosis. Front Microbiol. 2023;14:1217338. https:\/\/doi.org\/10.3389\/fmicb.2023.1217338.","journal-title":"Front Microbiol"}],"container-title":["Nutrition &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12986-026-01084-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12986-026-01084-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12986-026-01084-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T18:36:26Z","timestamp":1770834986000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12986-026-01084-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,17]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1084"],"URL":"https:\/\/doi.org\/10.1186\/s12986-026-01084-6","relation":{},"ISSN":["1743-7075"],"issn-type":[{"value":"1743-7075","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,17]]},"assertion":[{"value":"1 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval and consent to participate were waived because this study used the data from publicly available databases.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}